Allscripts Healthcare Solutions logo
Allscripts Healthcare Solutions MDRX
$ 6.81 -10.39%

Quarterly report 2022-Q4
added 11-07-2022

report update icon

Allscripts Healthcare Solutions Financial Statements 2011-2025 | MDRX

Annual Financial Statements Allscripts Healthcare Solutions

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.34 B 2.66 B 1.49 B 2.06 B 2.73 B 2.14 B 2.55 B 2.14 B 2.95 B 2.01 B 3.56 B

Shares

130 M 161 M 166 M 176 M 181 M 186 M 185 M 180 M 177 M 179 M 189 M

Historical Prices

18.4 14.4 9.82 9.64 14.6 10.2 15.4 12.8 15.5 9.42 18.9

Net Income

134 M 700 M -182 M 364 M -196 M -25.7 M -2.23 M -66.5 M -104 M -1.15 M 73.6 M

Revenue

1.5 B 1.5 B 1.77 B 1.75 B 1.81 B 1.55 B 1.39 B 1.38 B 1.37 B 1.45 B 1.44 B

Cost of Revenue

883 M 937 M 1.02 B 996 M 865 M 785 M 806 M 832 M 839 M 840 M 28.1 M

Gross Profit

620 M 566 M 714 M 725 M 782 M 671 M 581 M 546 M 534 M 607 M 666 M

Operating Income

77.2 M -131 M -99.7 M -168 M 12.5 M 67.7 M 31.9 M -39.2 M -128 M 13.3 M 137 M

Interest Expense

13.2 M 34.1 M 43.2 M 50.9 M 37.5 M 29.5 M 31.4 M 29.3 M 28.1 M 16.2 M 20.8 M

EBITDA

253 M -30.3 M 39.3 M 5.17 M 75.7 M 90.3 M 56.6 M -5.52 M -84.9 M 60 M 174 M

Operating Expenses

- 622 M 701 M 746 M 740 M 607 M 547 M 583 M 651 M 582 M 529 M

General and Administrative Expenses

314 M 390 M 420 M 451 M 486 M 393 M 339 M 359 M 420 M 384 M 388 M

All numbers in USD currency

Quarterly Income Statement Allscripts Healthcare Solutions

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- 110 M 114 M 116 M 116 M 124 M 137 M 140 M 140 M 161 M 163 M 162 M 162 M 166 M 167 M 170 M 171 M 175 M 176 M 180 M 181 M 181 M 181 M 181 M 181 M 186 M 187 M 189 M 189 M 189 M 182 M 181 M 180 M 180 M 180 M 179 M 179 M 178 M 178 M 174 M 172 M 171 M 182 M 191 M 190 M 188 M 190 M 189 K

Net Income

- 14.5 M -64 M 22.9 M - 16.2 M 21.9 M 9.06 M 728 M 542 K -7.6 M -20.4 M -19 M -5.72 M -150 M -7.98 M 386 M -23.8 M 74.3 M -28.5 M 14.9 M -17.5 M -143 M -20 M -7.31 M -10.2 M -10.2 M 2.05 M 16.3 M -5.24 M -3.22 M -10.1 M -2.18 M -25.8 M -17.8 M -20.7 M -20.6 M -48.9 M -22.9 M -11.6 M - 9.38 M 7.98 M 5.81 M - 19.1 M 15.9 M 12.6 M

Revenue

- 152 M 151 M 143 M 392 M 145 M 141 M 134 M 386 M 366 M 369 M 381 M 414 M 408 M 411 M 399 M 442 M 432 M 526 M 514 M 517 M 449 M 426 M 413 M 425 M 392 M 387 M 346 M 346 M 354 M 352 M 335 M 341 M 345 M 351 M 340 M 351 M 330 M 345 M 347 M - 361 M 370 M 365 M - 364 M 357 M 335 M

Cost of Revenue

- 68.5 M 71.4 M 69.2 M - 75 M 72.8 M 70.7 M 225 M 230 M 232 M 249 M 262 M 260 M 252 M 249 M 254 M 254 M 268 M 249 M 260 M 206 M 200 M 199 M 239 M 226 M 220 M 194 M 192 M 201 M 208 M 205 M 205 M 214 M 211 M 202 M 213 M 205 M 209 M 213 M - 204 M 212 M 209 M - 10 M 5 M 175 M

Gross Profit

- 83.4 M 79.5 M 73.5 M - 69.6 M 68.4 M 62.9 M 161 M 135 M 138 M 132 M 153 M 149 M 159 M 150 M 188 M 178 M 174 M 185 M 176 M 162 M 150 M 144 M 186 M 166 M 167 M 152 M 154 M 153 M 144 M 130 M 136 M 131 M 140 M 138 M 138 M 126 M 136 M 134 M - 157 M 157 M 156 M - 162 M 168 M 160 M

Operating Income

- 25 M -5.36 M 6.57 M - 18.5 M 16.8 M 7.73 M -68.1 M -11.2 M -24.7 M -27 M -55.1 M -15.7 M -13.6 M -15.3 M -26.4 M 186 K -60.1 M -6.7 M -21.3 M 18.2 M 13.2 M 2.35 M 12.4 M 16.9 M 18.6 M 11.9 M 23.1 M 8.87 M 5.59 M -5.7 M 656 K -18.8 M -9.09 M -11.9 M -27.5 M -43.5 M -28.3 M -28.3 M - 9.18 M 17.7 M 13 M - 34.4 M 32.1 M 24.5 M

Interest Expense

- 1.25 M 1.89 M 2.14 M - 3.62 M 2.95 M 3.14 M 6.46 M 6.67 M 10.3 M 10.7 M 11.7 M 10.8 M 10.4 M 10.2 M 14 M 13.3 M 12 M 11.7 M 11.6 M 9.25 M 8.28 M 8.42 M 25.4 M 19.4 M 16.4 M 6.97 M -98 K 423 K -28 K 7.26 M 7.29 M 7.54 M 7.23 M 7.23 M 7.02 M 6.9 M 9.5 M 4.64 M - 3.72 M 4.36 M 3.85 M - 3.75 M 5.05 M 7.93 M

EBITDA

- 67.3 M 23.1 M 20.7 M - 67.5 M 49.8 M 24 M -68.1 M 135 M 74.6 M 22.5 M -55.1 M 137 M 87 M 34.9 M -19.5 M 143 M 35.1 M 41.2 M -15.3 M 173 M 115 M 52 M 23.3 M 137 M 95.2 M 46.3 M 27.3 M 133 M 89.1 M 36 M 9.52 M 113 M 79.6 M 33.2 M -19.9 M 88.3 M 56.6 M 13.7 M - 120 M 90.6 M 48.2 M - 132 M 95.8 M 55.3 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 352 M - - - 311 M

General and Administrative Expenses

- 32.5 M 59.8 M 41.3 M - 27.4 M 28.1 M 32.2 M 93.8 M 93.4 M 110 M 92.8 M 108 M 96.1 M 100 M 96 M 100 M 108 M 123 M 120 M 123 M 93.8 M 91 M 92.8 M 115 M 98.8 M 94.8 M 84.2 M 79.4 M 91 M 86.7 M 82 M 85 M 97 M 86.7 M 89.9 M 109 M 105 M 102 M 104 M - 90.4 M 92.3 M 97.3 M - 92.2 M 102 M 104 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Allscripts Healthcare Solutions MDRX
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Allscripts Healthcare Solutions plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Health information services industry

Issuer Price % 24h Market Cap Country
Computer Programs and Systems Computer Programs and Systems
CPSI
$ 9.25 4.4 % $ 133 M usaUSA
HealthStream HealthStream
HSTM
$ 27.18 1.08 % $ 826 M usaUSA
Covetrus Covetrus
CVET
$ 20.99 - $ 2.94 B usaUSA
NantHealth NantHealth
NH
$ 1.35 -46.64 % $ 10.4 M usaUSA
Cerner Corporation Cerner Corporation
CERN
$ 94.92 - $ 27.9 B usaUSA
Castlight Health, Inc. Castlight Health, Inc.
CSLT
$ 1.4 -7.28 % $ 227 M -
Change Healthcare Change Healthcare
CHNG
$ 27.49 - $ 9.03 B usaUSA
HMS Holdings Corp. HMS Holdings Corp.
HMSY
$ 36.975 - $ 3.29 B usaUSA
Inovalon Holdings, Inc. Inovalon Holdings, Inc.
INOV
$ 41.06 - $ 6.37 B usaUSA
R1 RCM R1 RCM
RCM
$ 14.31 - $ 3.81 B usaUSA
1Life Healthcare 1Life Healthcare
ONEM
$ 16.47 - $ 3.37 B usaUSA
Signify Health Signify Health
SGFY
$ 30.49 -0.02 % $ 7.21 B -
10x Genomics 10x Genomics
TXG
$ 12.07 4.05 % $ 1.41 B usaUSA
NextGen Healthcare NextGen Healthcare
NXGN
$ 23.94 - $ 1.6 B usaUSA
Tabula Rasa HealthCare Tabula Rasa HealthCare
TRHC
$ 10.5 - $ 255 M usaUSA
Zhongchao Zhongchao
ZCMD
$ 1.17 -2.51 % $ 6.09 M chinaChina
MTBC MTBC
MTBC
$ 3.43 -0.58 % $ 51.7 M usaUSA
GoodRx Holdings GoodRx Holdings
GDRX
$ 4.39 - $ 1.69 B usaUSA
HealthEquity HealthEquity
HQY
$ 92.09 4.06 % $ 7.88 B usaUSA
Health Catalyst Health Catalyst
HCAT
$ 2.85 - $ 172 M usaUSA
Progyny Progyny
PGNY
$ 20.58 2.9 % $ 1.77 B usaUSA
iCAD iCAD
ICAD
$ 3.87 - $ 102 M usaUSA
American Well Corporation American Well Corporation
AMWL
$ 6.26 3.64 % $ 93.9 M usaUSA
Evolent Health Evolent Health
EVH
$ 8.05 -0.8 % $ 754 M usaUSA
Omnicell Omnicell
OMCL
$ 31.45 3.97 % $ 1.45 B usaUSA
SCWorx Corp. SCWorx Corp.
WORX
$ 0.31 0.66 % $ 452 K usaUSA
Akerna Corp. Akerna Corp.
KERN
$ 6.27 - $ 161 M usaUSA
OptimizeRx Corporation OptimizeRx Corporation
OPRX
$ 18.24 1.62 % $ 312 M usaUSA
Phreesia Phreesia
PHR
$ 23.25 -0.68 % $ 1.27 B usaUSA
Premier Premier
PINC
$ 28.21 1.07 % $ 2.32 B usaUSA
Accolade Accolade
ACCD
$ 7.03 0.29 % $ 206 M usaUSA
Streamline Health Solutions Streamline Health Solutions
STRM
$ 5.33 - $ 21.4 M usaUSA
Teladoc Health Teladoc Health
TDOC
$ 9.09 8.6 % $ 1.55 B usaUSA
Schrödinger Schrödinger
SDGR
$ 20.72 2.78 % $ 1.51 B usaUSA
Veeva Systems Veeva Systems
VEEV
$ 301.8 -1.44 % $ 48.4 B -
So-Young International So-Young International
SY
$ 3.81 0.26 % $ 302 M chinaChina